FDA approves imaging drug for detecting cancer after lumpectomy
Editor's Note The US Food and Drug Administration (FDA) approved Lumisight (pegulicianine), a fluorescent imaging drug used to detect cancerous tissue during lumpectomy, on April 17. Administered intravenously prior to surgery, Lumisight is designed for use with the Lumicell Direct Visualization System (DVS) or another imaging device that is FDA-approved…
Online breast cancer surgery information too difficult to understand
Editor's Note Online breast cancer surgery information is often difficult to understand and may be impeding people’s ability to make informed decisions about their care, US News October 25 reports. Researchers reviewed patient education materials describing breast-conserving surgery, mastectomy, and lymph node surgery from US National Cancer Institute related websites…
New AI tool matches human precision in assessing surgical margins for breast cancer
Editor's Note Researchers from the University of North Carolina developed an artificial intelligence (AI) model that can predict whether cancerous tissue has been fully removed from the body during breast cancer surgical procedures. Their findings were published in the Annals of Surgical Oncology August 2023 issue. During the procedure, surgeons…
Free Daily News
- Carbon-conscious health systems phase out desflurane anesthesia gas to reduce emissions
- Joint Commission releases annual Sentinel Event Data Report
- Study: Surgical team diversity improves patient outcomes
- Colorectal cancer rates declining in older adults, rising among children, teens
- Industry leaders share main growth opportunities for ASCs
- US News & World Report best ASCs ranking now available
- Study: Standard preoperative fasting instructions sufficient for diabetic patients
- Survey: More than half of nurses pessimistic about 2024, ready to change jobs
- WHO guidelines target catheter-caused infections
- FDA issues class 1 recall for medical catheters